Clinical Trial Comparing Standard Care Versus Prehabilitation in Patients Undergoing Cancer Surgery
- Conditions
- Cancer of ColonCancer of RectumLiver Metastases
- Interventions
- Other: Prehabilitation
- Registration Number
- NCT04880772
- Lead Sponsor
- East Lancashire Hospitals NHS Trust
- Brief Summary
To determine whether exercise and nutrition prehabilitation improves patient outcomes after cancer surgery
- Detailed Description
Preliminary qualitative and quantitative studies suggest that there are benefits (reduced length of stay, improved cardiorespiratory function, reduced postoperative complications and improved quality of life) when prehabilitation is used with the context of cancer care. In 2017 Macmillian Cancer Support developed a strategic 'Evidence and Insight' review on prehabilitation. The outcome of this was to incorporate prehabilitation into routine cancer care and to develop principles and guidance for prehabilitation. This study aims to support this vision and answer some of the questions on the patients who are most likely to benefit from prehabilitation and to quantify some of these benefits by investigating the molecular processes that influence clinical changes
This study primarily seeks to assess the cardiovascular and biological impact of prehabilitation (exercise, nutrition) on patients undergoing hepatobiliary and colorectal cancer surgery. The investigators aim to assess whether there is an improvement in various cardiopulmonary exercise testing (CPET) variables such as maximum oxygen consumption and anaerobic threshold. The investigators also aim to study the inflammatory cytokines associated with cancer and how these markers respond to exercise. These inflammatory markers are thought to play a role in influencing some clinical outcomes such as wound infection and recovery.
The study will also assess secondary outcomes including hospital stay, post operative complications and quality of life. The investigators aim to better understand the biological relationship between anti-inflammatory cytokine levels and the previously mentioned outcomes by measuring and analysing these mediators and performing selected muscle biopsies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 42
- Aged 18-85
- Sex: male/female
- Radiological/tissue cancer diagnosis
- Curative cancer of the colon, rectum, colorectal liver metastases (CRLM) of 2 or more segments
- elective surgery (planned a minimum of 3 weeks from the date of first clinic meeting)
- Access to digital technology(mobile phone, tablet or laptop, home computer) to participate in supervised home exercise
Exclusion
- Palliative disease
- Haematological malignancy
- Pregnancy
- Emergency surgery
- Physically unable to undergo CPET
- Part of any other trial with similar interventions unless previously agreed on with all CIs
- synchronous disease (operation on HPB & colorectal cancers at the same operation)
- No access to digital technology(smart phone, tablet, laptop or home computer)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Prehabilitation Prehabilitation Surgery School plus Moderate intensity exercise \& Forceval (multivitamin)
- Primary Outcome Measures
Name Time Method Inflammatory cytokines change in baseline cytokines at 4 weeks IL6 IL10 in muscle and blood measured in pg/ml
Anaerobic threshold (AT) measured in ml/kg/min and maximum oxygen consumption ( VO2 peak) measured in ml/kg/min change in baseline AT & VO2 peak at 4 weeks Cardiopulmonary exercise Test (CPET) variables
- Secondary Outcome Measures
Name Time Method Clavien-Dindo complication rates Up to 30 days from the day of operation Grades I-IV
Hand Grip Strength measured in kg baseline, immediately after the intervention, within 24 weeks after surgery Measured by digital dynamometer
Length of hospital stay measured in days 30 & 90-day mortality Defined as duration of stay from date of operation to discharge
Quality of life measures (Illness Perception Questionnaire) baseline and within 24 weeks after surgery This questionnaire assesses perceptions on each of the five dimensions(Identity, Cause, Timeline, Consequences, Cure-Control) by asking patients for their own beliefs about their condition.
High scores on the identity, consequences, timeline acute/ chronic and cyclical subscales represent strongly held beliefs about the number of symptoms attributed, the negative consequences, and the chronicity and cyclical nature of the illness.
High scores on the identity and cure-control and coherence subscales represent positive beliefs about controllability and a personal understanding of the illness.Quality of life measure (Mental Adjustment to Cancer Scale) baseline and within 24 weeks after surgery Assessment of participants mental adjustment to a cancer diagnosis. Designed to measure Fighting Spirit (FS), Anxious Preoccupation (AP), Helpless-hopelessness (HH) and Fatalism. This is a 40-item measure of specific psychological (Coping) responses that cancer patients may display in the process of adjusting to the diagnosis and treatment of their disease.
A higher score represents higher endorsement of the adjustment response.
Trial Locations
- Locations (1)
Royal Blackburn Hospital
🇬🇧Blackburn, United Kingdom